Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
$ 0.03
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
DSwiss, Inc., a biotech-nutraceutical company, supplies health and beauty products in Malaysia, Singapore, Indonesia, Taiwan, Macau, Hong Kong, and China. Its products include DSwiss coffee for digestive health; DSwiss kiwi, which helps the body's immune system, as well as enhances skin complexion, reduces blood pressure, and prevents heart disease and stroke; DSwiss Triple SC that...
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is 'expensive' on EV/EBITDA.
Data is available to registered users only
Buy
Sell